0001209191-20-060298.txt : 20201124 0001209191-20-060298.hdr.sgml : 20201124 20201124175703 ACCESSION NUMBER: 0001209191-20-060298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201122 FILED AS OF DATE: 20201124 DATE AS OF CHANGE: 20201124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Papapetropoulos Spyridon CENTRAL INDEX KEY: 0001832694 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 201345758 MAIL ADDRESS: STREET 1: C/O ADAMAS PHARMACEUTICALS, INC. STREET 2: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER NAME: FORMER CONFORMED NAME: Papapetopoulos Spyridon DATE OF NAME CHANGE: 20201117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-22 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001832694 Papapetropoulos Spyridon C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL STREET, SUITE 1000 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2020-11-22 4 A 0 10000 0.00 A 10000 D Stock Option (Rightto Buy) 4.35 2020-11-22 4 A 0 20000 0.00 A 2030-11-21 Common Stock 20000 20000 D Represents the grant of restricted stock units that vest annually in equal installments over 3 years. The shares subject to the option vest annually in equal installments over 3 years. /s/ Christopher Prentiss, Attorney-in-fact 2020-11-24